Skip to main content
COGT logo

COGT · Cogent Biosciences, Inc.

Track COGT — free
$37.93 +0.62 (+1.66%) At close · Aug 14
Market Cap
$6.58B
Shares
173.52M

Cogent Biosciences, Inc. Earnings Call Transcripts

Every quarterly earnings call for Cogent Biosciences, Inc. (COGT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference in New York
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-05
Cogent Biosciences, Inc. Q1 FY2026 Earnings Call
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Cogent Biosciences, Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Cogent Biosciences, Inc. Q3 FY2025 Earnings Call
Diluted EPS
$-0.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Cogent Biosciences, Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Cogent Biosciences, Inc. Q3 FY2024 Earnings Call
Diluted EPS
$-0.52
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-26
Cogent Biosciences, Inc. Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Cogent Biosciences, Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.64
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-08
Cogent Biosciences, Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-0.59
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Cogent Biosciences, Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-0.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-11-14
Cogent Biosciences, Inc. Q3 FY2022 Earnings Call
Diluted EPS
$-0.50
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-15
Cogent Biosciences, Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–12 of 12 earnings calls
Key facts CIK 1622229 CUSIP 19240Q201 13F (30d) 312 filings 308 filers Visit website Investor relations